The ITTA revealed a successful outcome in 67.9 % v 44.3 % of patients who had received combination therapy and monotherapy , respectively ( 127/187 v 90/203 ; absolute difference in risk ( adr ) , 23.6 % ; 95 % CI , 14 % to 33 % ; P < .001 ) .